Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered (Q42490341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Antonio V Gaddi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Arrigo Fg Cicero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Giovanni Gambaro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

6 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Nephrology and Renovascular Disease

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

99-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

5 February 2020

copyright license

start time

1 July 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cardiovascular risk and management in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Rationale and strategies for early detection and management of diabetic kidney disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Revisiting the glomerular charge barrier in the molecular era.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

The role of sulodexide in the treatment of diabetic nephropathy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Emerging therapeutic strategies in diabetic nephropathy.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Anti-proteinuric effects of glycosaminoglycan-based drugs

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

New approaches to the treatment of dense deposit disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

One year course of oral sulodexide in the management of diabetic nephropathy.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Structural insights into biological roles of protein-glycosaminoglycan interactions

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

The effect of glycosaminoglycan sulodexide on albuminuria in patients with diabetes mellitus

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Vascular dementia Italian sulodexide study (VA.D.I.S.S.). Clinical and biological results.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Inhibition of neointimal proliferation of rat carotid artery by sulodexide

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while supressing cellular proliferation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Methods of prevention of ischemic cerebral damages in patients with antiphospholipid antibodies

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Anti-inflammatory effect of sulodexide during acute peritonitis in rats

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

A study on the safety, efficacy, and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs?

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Images in cardiovascular medicine. Carotid plaque reduction after medical treatment

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

A pilot study of the effect of the glycosaminoglycan sulodexide on microalbuminuria in type I diabetic patients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

Investigational drugs for diabetic nephropathy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3108767

A randomized, controlled study of sulodexide therapy for the treatment of diabetic nephropathy

1 December 2018

1 reference

12 December 2020

Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients

1 reference

12 December 2020

Glycosaminoglycans Delay the Progression of Nephropathy in NIDDM

1 reference

12 December 2020

Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system

1 reference

12 December 2020

1 reference

12 December 2020

Glycosaminoglycans as a possible tool for micro- and macroalbuminuria in diabetic patients. A pilot study

1 reference

12 December 2020

Glomerular filtration: the charge debate charges ahead

1 reference

12 December 2020

Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria

1 reference

12 December 2020

Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease

1 reference

12 December 2020

Overweight, obesity and chronic kidney disease

1 reference

12 December 2020

[The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy]

1 reference

12 December 2020

[A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy]

1 reference

12 December 2020

Effect of glycosaminoglycans on urinary albumin excretion in insulin-dependent diabetic patients with micro- or macroalbuminuria

1 reference

12 December 2020

Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis

1 reference

12 December 2020

Evaluation of endothelium-protective effects of drugs in experimental models of endothelial damage

1 reference

12 December 2020

Pharmacokinetics and distribution of a fluoresceinated glycosaminoglycan, sulodexide, in rats. Part II: Organ distribution in rats

1 reference

12 December 2020

Agents in development for the treatment of diabetic nephropathy

1 reference

12 December 2020

The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus

1 reference

12 December 2020

[The effect of sulodexide, a glycosaminoglycan, on albuminuria in diabetic patients]

1 reference

12 December 2020

[Sulodexide in the treatment of diabetic nephropathy]

1 reference

12 December 2020

Identifiers

DOI

10.2147/IJNRD.S5943

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21694935%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

21694935

1 reference